Learning Deficits in Adolescence Linked to Novel Brain Receptor:
Mar 19, 2010
Could a Pill Increase Learning Ability Post-Puberty?
It is well known that the onset of puberty marks the end of the optimal period for learning language and certain spatial skills, such as computer/video game operation. Recent work published in the journal Science by Sheryl Smith, PhD, professor of physiology and pharmacology, and colleagues at SUNY Downstate Medical Center in Brooklyn shows that a novel brain receptor, alpha four-beta-delta GABA-A, emerges at puberty in the hippocampus, part of the brain that controls learning and memory.
Before puberty, expression of this receptor is low and learning is optimal. However, at puberty, increases in this receptor reduce brain excitability and impair spatial learning. Dr. Smith has demonstrated that this learning deficit can be reversed by a stress steroid that diminishes the harmful effects of the alpha four-beta-delta receptors, thereby facilitating learning.
“These findings suggest that intrinsic brain mechanisms alter learning during adolescence, but that mild stress may be one factor that can reverse this decline in learning proficiency during the teenage years,” says Dr. Smith. “They also suggest that different strategies for learning and motivation may be helpful in middle school. And it is within the realm of possibility that a drug could be developed that would increase learning ability post-puberty, one that might be especially useful for adolescents with learning disabilities.”
In 2007, Dr. Smith and colleagues demonstrated that a hormone normally released in response to stress, THP, actually reverses its effect at puberty, when it increases activity of the hippocampus. While in adults this hormone acts like at tranquilizer, in adolescents it has the opposite effect, an action that may help to explain mood swings in teenagers.
###
About SUNY Downstate Medical Center
SUNY Downstate Medical Center, founded in 1860, was the first medical school in the United States to bring teaching out of the lecture hall and to the patient’s bedside. A center of innovation and excellence in research and clinical service delivery, SUNY Downstate Medical Center comprises a College of Medicine, College of Nursing, School of Health Professions, a School of Graduate Studies, School of Public Health, University Hospital of Brooklyn, and a multifaceted biotechnology initiative including the Downstate Biotechnology Incubator and BioBAT for early-stage and more mature companies, respectively.
SUNY Downstate ranks twelfth nationally in the number of alumni who are on the faculty of American medical schools. More physicians practicing in New York City have graduated from SUNY Downstate than from any other medical school.